Dr. Thomas Hoeger
Chief Executive Officer
Thomas Hoeger, Ph.D., has been Chief Executive Officer of Apogenix since November 2005. He also oversees the preclinical and clinical development departments at Apogenix. Previously, he worked as a biotech analyst for DZ Bank in Frankfurt, Germany, for five years. From 1997 to 2000, he headed the 'Central Nervous System' research at BASF AG and Knoll AG. During the previous six years, he held various research and management positions at BASF AG.
Following his studies in biology at the Universities of Kiel and Heidelberg as scholar of the German Academic Scholarship Foundation in Germany, and as Fulbright Scholar at the Massachusetts Institute of Technology (MIT) in Cambridge, MA, USA, Dr. Hoeger obtained his Ph.D. in 1991 with highest honors for the doctoral work performed at the German Cancer Research Center (DKFZ) in Heidelberg, Germany. In 2001, he completed his training as Certified European Financial Analyst (CEFA).
Phone: +49 (0)6221 586080